would anyone care to explain why our trials of NNZ 2591 for Prader-Willi syndrome are subject to much stricter safety protocols than our competitors' drugs for the same indication? Is NEU being unfairly treated by the FDA? Why are their safety protocols so lenient?
- Forums
- ASX - By Stock
- Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
would anyone care to explain why our trials of NNZ 2591 for...
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.80 |
Change
0.300(1.54%) |
Mkt cap ! $2.528B |
Open | High | Low | Value | Volume |
$19.49 | $19.92 | $19.25 | $5.352M | 271.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $19.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.80 | 516 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 19.780 |
2 | 1143 | 19.750 |
1 | 1441 | 19.740 |
1 | 5505 | 19.720 |
3 | 3263 | 19.700 |
Price($) | Vol. | No. |
---|---|---|
19.820 | 1081 | 2 |
19.890 | 150 | 1 |
19.900 | 2000 | 1 |
19.940 | 1143 | 2 |
19.950 | 1948 | 2 |
Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
Last
$19.80 |
  |
Change
0.300 ( 0.98 %) |
|||
Open | High | Low | Volume | ||
$19.41 | $19.92 | $19.25 | 77870 | ||
Last updated 15.59pm 17/06/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online